{
  "openalex_id": "W2155420645",
  "doi": "https://doi.org/10.18632/oncotarget.1878",
  "title": "PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation",
  "abstract": "// Francesco Sabbatino 1,3,4,* , Yangyang Wang 1,3,* , Xinhui Wang 1,3 , Keith T. Flaherty 2,3 , Ling Yu 5,7 , David Pepin 1,3 , Giosue' Scognamiglio 5,8 , Stefano Pepe 4,10 , John M. Kirkwood 6 , Zachary A. Cooper 1,3,9 , Dennie T. Frederick 1,3 , Jennifer A. Wargo 1,3,9 , Soldano Ferrone 1,3 , Cristina R. Ferrone 1,3 1 Department of Surgery, Massachusetts General Hospital, Boston, MA 2 Department of Medical Oncology, Massachusetts General Hospital, Boston, MA 3 Harvard Medical School, Boston, MA 4 Department of Clinical and Molecular Oncology and Endocrinology, University of Naples \"Federico II\", Naples, Italy 5 Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pittsburgh, PA 6 Department of Medicine, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pittsburgh, PA 7 Institute for Clean Energy & Advanced Materials, Southwest University, Chongqing, P.R. China 8 Pathology Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy 9 Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 10 Department of Medicine, University of Salerno, Salerno, Italy * These authors contributed equally to this work Correspondence: Soldano Ferrone, email: // Keywords : BRAF inhibitor resistance, PDGFRα up-regulation, PDGFRα inhibitors, melanoma, sonic hedgehog pathway, LDE225. Received : February 13, 2014 Accepted : March 31, 2014 Published : March 31, 2014 Abstract Control of BRAF(V600E) metastatic melanoma by BRAF inhibitor (BRAF-I) is limited by intrinsic and acquired resistance. Growth factor receptor up-regulation is among the mechanisms underlying BRAF-I resistance of melanoma cells. Here we demonstrate for the first time that PDGFRα up-regulation causes BRAF-I resistance. PDGFRα inhibition by PDGFRα-specific short hairpin (sh)RNA and by PDGFRα inhibitors restores and increases melanoma cells' sensitivity to BRAF-I in vitro and in vivo . This effect reflects the inhibition of ERK and AKT activation which is associated with BRAF-I resistance of melanoma cells. PDGFRα up-regulation is mediated by Sonic Hedgehog Homolog (Shh) pathway activation which is induced by BRAF-I treatment. Similarly to PDGFRα inhibition, Shh inhibition by LDE225 restores and increases melanoma cells' sensitivity to BRAF-I. These effects are mediated by PDGFRα down-regulation and by ERK and AKT inhibition. The clinical relevance of these data is indicated by the association of PDGFRα up-regulation in melanoma matched biopsies of BRAF-I +/- MEK inhibitor treated patients with shorter time to disease progression and less tumor regression. These findings suggest that monitoring patients for early PDGFRα up-regulation will facilitate the identification of those who may benefit from the treatment with BRAF-I in combination with clinically approved PDGFRα or Shh inhibitors.",
  "authors": [
    {
      "display_name": "Francesco Sabbatino",
      "id": "A5010570032",
      "orcid": "https://orcid.org/0000-0001-6431-8278",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I71267560",
          "display_name": "University of Naples Federico II",
          "country_code": "IT",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Francesco Sabbatino"
    },
    {
      "display_name": "Yangyang Wang",
      "id": "A5100345125",
      "orcid": "https://orcid.org/0000-0002-3024-305X",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Yangyang Wang"
    },
    {
      "display_name": "Xinhui Wang",
      "id": "A5100370823",
      "orcid": "https://orcid.org/0000-0001-5579-1311",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Xinhui Wang"
    },
    {
      "display_name": "Keith T. Flaherty",
      "id": "A5023174631",
      "orcid": "https://orcid.org/0000-0002-3402-0478",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Keith T. Flaherty"
    },
    {
      "display_name": "Ling Yu",
      "id": "A5100681417",
      "orcid": "https://orcid.org/0000-0002-6726-281X",
      "institutions": [
        {
          "id": "I4210128526",
          "display_name": "UPMC Hillman Cancer Center",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I142108993",
          "display_name": "Southwest University",
          "country_code": "CN",
          "type": "funder"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Ling Yu"
    },
    {
      "display_name": "David Pépin",
      "id": "A5090769989",
      "orcid": "https://orcid.org/0000-0003-2046-6708",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David Pepin"
    },
    {
      "display_name": "Giosuè Scognamiglio",
      "id": "A5049219849",
      "orcid": "https://orcid.org/0000-0003-4376-111X",
      "institutions": [
        {
          "id": "I4210128526",
          "display_name": "UPMC Hillman Cancer Center",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4210141868",
          "display_name": "Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"",
          "country_code": "IT",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Giosue’ Scognamiglio"
    },
    {
      "display_name": "Stefano Pepe",
      "id": "A5064816004",
      "orcid": "https://orcid.org/0000-0003-0057-8411",
      "institutions": [
        {
          "id": "I71267560",
          "display_name": "University of Naples Federico II",
          "country_code": "IT",
          "type": "funder"
        },
        {
          "id": "I131729948",
          "display_name": "University of Salerno",
          "country_code": "IT",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Stefano Pepe"
    },
    {
      "display_name": "John M. Kirkwood",
      "id": "A5007239425",
      "orcid": "https://orcid.org/0000-0002-3570-4476",
      "institutions": [
        {
          "id": "I4210128526",
          "display_name": "UPMC Hillman Cancer Center",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "John M. Kirkwood"
    },
    {
      "display_name": "Zachary A. Cooper",
      "id": "A5071770314",
      "orcid": "https://orcid.org/0000-0003-1059-0940",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Zachary A. Cooper"
    },
    {
      "display_name": "Dennie T. Frederick",
      "id": "A5047185974",
      "orcid": "https://orcid.org/0000-0003-3355-5267",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Dennie T. Frederick"
    },
    {
      "display_name": "Jennifer A. Wargo",
      "id": "A5035427219",
      "orcid": "https://orcid.org/0000-0003-3438-7576",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jennifer A. Wargo"
    },
    {
      "display_name": "Soldano Ferrone",
      "id": "A5028669896",
      "orcid": "https://orcid.org/0000-0003-2900-8834",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": true,
      "raw_author_name": "Soldano Ferrone"
    },
    {
      "display_name": "Cristina R. Ferrone",
      "id": "A5103094053",
      "orcid": "https://orcid.org/0000-0002-9465-7008",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Cristina R. Ferrone"
    }
  ],
  "publication_year": 2014,
  "publication_date": "2014-03-31",
  "type": "article",
  "cited_by_count": 59,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S126644158",
    "display_name": "Oncotarget",
    "issn_l": "1949-2553",
    "issn": [
      "1949-2553"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316297"
  },
  "volume": "5",
  "issue": "7",
  "first_page": "1926",
  "last_page": "1941",
  "open_access": {
    "is_oa": true,
    "oa_status": "gold",
    "oa_url": "https://www.oncotarget.com/article/1878/pdf/",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C2777658100",
      "display_name": "Melanoma",
      "level": 2,
      "score": 0.76945615
    },
    {
      "id": "C502942594",
      "display_name": "Cancer research",
      "level": 1,
      "score": 0.70792454
    },
    {
      "id": "C57074206",
      "display_name": "MAPK/ERK pathway",
      "level": 3,
      "score": 0.6613026
    },
    {
      "id": "C180361614",
      "display_name": "Platelet-derived growth factor receptor",
      "level": 4,
      "score": 0.59916407
    },
    {
      "id": "C2776637008",
      "display_name": "Sonic hedgehog",
      "level": 3,
      "score": 0.565538
    },
    {
      "id": "C2776131300",
      "display_name": "Vemurafenib",
      "level": 4,
      "score": 0.55938333
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.55539215
    },
    {
      "id": "C2781249067",
      "display_name": "MEK inhibitor",
      "level": 4,
      "score": 0.5341047
    },
    {
      "id": "C26375932",
      "display_name": "Growth factor receptor",
      "level": 3,
      "score": 0.46006146
    },
    {
      "id": "C88498014",
      "display_name": "Hedgehog signaling pathway",
      "level": 3,
      "score": 0.45972154
    },
    {
      "id": "C75217442",
      "display_name": "Protein kinase B",
      "level": 3,
      "score": 0.45064622
    },
    {
      "id": "C86554907",
      "display_name": "PI3K/AKT/mTOR pathway",
      "level": 3,
      "score": 0.44090438
    },
    {
      "id": "C2775960820",
      "display_name": "Growth factor",
      "level": 3,
      "score": 0.33419806
    },
    {
      "id": "C86803240",
      "display_name": "Biology",
      "level": 0,
      "score": 0.31664985
    },
    {
      "id": "C62478195",
      "display_name": "Signal transduction",
      "level": 2,
      "score": 0.28377888
    },
    {
      "id": "C170493617",
      "display_name": "Receptor",
      "level": 2,
      "score": 0.25337917
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.2505437
    },
    {
      "id": "C2994587330",
      "display_name": "Metastatic melanoma",
      "level": 3,
      "score": 0.07055983
    },
    {
      "id": "C95444343",
      "display_name": "Cell biology",
      "level": 1,
      "score": 0.06751123
    }
  ],
  "topics": [
    {
      "id": "T11533",
      "display_name": "Melanoma and MAPK Pathways",
      "score": 0.9999
    },
    {
      "id": "T10755",
      "display_name": "HER2/EGFR in Cancer Research",
      "score": 0.9947
    },
    {
      "id": "T11591",
      "display_name": "NF-κB Signaling Pathways",
      "score": 0.9911
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.18632/oncotarget.1878",
  "pdf_url": "https://www.oncotarget.com/article/1878/pdf/",
  "retrieved_date": "2025-07-30T15:39:16.221298",
  "source_database": "OpenAlex"
}